| Louie A Anquilo, MD | |
|
14214 Ballantyne Lake Rd, Ste 100, Charlotte, NC 28277-3372 | |
| (704) 667-2650 | |
| Not Available |
| Full Name | Louie A Anquilo |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 14214 Ballantyne Lake Rd, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275649618 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2008-01015 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Hospice Llc | Piedmont, SC | Hospice |
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolinas Physicians Network Inc | 3375449655 | 1613 |
News Archive
Integra LifeSciences Holdings Corporation announced today that it has entered into an exclusive worldwide license and development agreement with Stout Medical Group, LP to develop and commercialize an expandable interbody device.
Jan A. Nowak, PhD, MD, has been awarded the Association for Molecular Pathology 2013 Leadership Award. This is the highest honor that AMP gives exclusively to one of its members - one who has demonstrated exceptional leadership in the accomplishment of the mission and vision of AMP.
The American Recovery and Reinvestment Act (ARRA) has provided funding for new research to learn more about how white blood cells work. Jonathan Reichner, PhD, of the department of surgery at Rhode Island Hospital has received a grant from the National Institutes of Health with funding through the American Recovery and Reinvestment Act. Reichner's hope is that the research will lead to new immune-enhancing therapies, with potential implications for improvements in both cancer treatment and controlling inflammation accompanying injury and infection.
Johns Hopkins and Yale scientists have found that melanoma cells use a cloaking protein to hide from immune cells poised to attack the cancer. Nearly 40 percent of their sampling of melanoma tissues contained the B7-H1 protein, also called PD-L1, and scientists say it could be used as a target for new therapies.
Breast cancer begins when the cells in the breast begin to grow out of control. The cells form a tumor, which can become malignant if they invade and spread to surrounding tissues. Like any other cancers, breast cancer has many risk factors that can't be changed, like family history.
› Verified 6 days ago
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962858662 PECOS PAC ID: 3375449655 Enrollment ID: O20031209000106 |
News Archive
Integra LifeSciences Holdings Corporation announced today that it has entered into an exclusive worldwide license and development agreement with Stout Medical Group, LP to develop and commercialize an expandable interbody device.
Jan A. Nowak, PhD, MD, has been awarded the Association for Molecular Pathology 2013 Leadership Award. This is the highest honor that AMP gives exclusively to one of its members - one who has demonstrated exceptional leadership in the accomplishment of the mission and vision of AMP.
The American Recovery and Reinvestment Act (ARRA) has provided funding for new research to learn more about how white blood cells work. Jonathan Reichner, PhD, of the department of surgery at Rhode Island Hospital has received a grant from the National Institutes of Health with funding through the American Recovery and Reinvestment Act. Reichner's hope is that the research will lead to new immune-enhancing therapies, with potential implications for improvements in both cancer treatment and controlling inflammation accompanying injury and infection.
Johns Hopkins and Yale scientists have found that melanoma cells use a cloaking protein to hide from immune cells poised to attack the cancer. Nearly 40 percent of their sampling of melanoma tissues contained the B7-H1 protein, also called PD-L1, and scientists say it could be used as a target for new therapies.
Breast cancer begins when the cells in the breast begin to grow out of control. The cells form a tumor, which can become malignant if they invade and spread to surrounding tissues. Like any other cancers, breast cancer has many risk factors that can't be changed, like family history.
› Verified 6 days ago
| Entity Name | Senior Health Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023155728 PECOS PAC ID: 6204739881 Enrollment ID: O20040130000360 |
News Archive
Integra LifeSciences Holdings Corporation announced today that it has entered into an exclusive worldwide license and development agreement with Stout Medical Group, LP to develop and commercialize an expandable interbody device.
Jan A. Nowak, PhD, MD, has been awarded the Association for Molecular Pathology 2013 Leadership Award. This is the highest honor that AMP gives exclusively to one of its members - one who has demonstrated exceptional leadership in the accomplishment of the mission and vision of AMP.
The American Recovery and Reinvestment Act (ARRA) has provided funding for new research to learn more about how white blood cells work. Jonathan Reichner, PhD, of the department of surgery at Rhode Island Hospital has received a grant from the National Institutes of Health with funding through the American Recovery and Reinvestment Act. Reichner's hope is that the research will lead to new immune-enhancing therapies, with potential implications for improvements in both cancer treatment and controlling inflammation accompanying injury and infection.
Johns Hopkins and Yale scientists have found that melanoma cells use a cloaking protein to hide from immune cells poised to attack the cancer. Nearly 40 percent of their sampling of melanoma tissues contained the B7-H1 protein, also called PD-L1, and scientists say it could be used as a target for new therapies.
Breast cancer begins when the cells in the breast begin to grow out of control. The cells form a tumor, which can become malignant if they invade and spread to surrounding tissues. Like any other cancers, breast cancer has many risk factors that can't be changed, like family history.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Louie A Anquilo, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Louie A Anquilo, MD 14214 Ballantyne Lake Rd, Ste 100, Charlotte, NC 28277-3372 Ph: (704) 667-2650 |
News Archive
Integra LifeSciences Holdings Corporation announced today that it has entered into an exclusive worldwide license and development agreement with Stout Medical Group, LP to develop and commercialize an expandable interbody device.
Jan A. Nowak, PhD, MD, has been awarded the Association for Molecular Pathology 2013 Leadership Award. This is the highest honor that AMP gives exclusively to one of its members - one who has demonstrated exceptional leadership in the accomplishment of the mission and vision of AMP.
The American Recovery and Reinvestment Act (ARRA) has provided funding for new research to learn more about how white blood cells work. Jonathan Reichner, PhD, of the department of surgery at Rhode Island Hospital has received a grant from the National Institutes of Health with funding through the American Recovery and Reinvestment Act. Reichner's hope is that the research will lead to new immune-enhancing therapies, with potential implications for improvements in both cancer treatment and controlling inflammation accompanying injury and infection.
Johns Hopkins and Yale scientists have found that melanoma cells use a cloaking protein to hide from immune cells poised to attack the cancer. Nearly 40 percent of their sampling of melanoma tissues contained the B7-H1 protein, also called PD-L1, and scientists say it could be used as a target for new therapies.
Breast cancer begins when the cells in the breast begin to grow out of control. The cells form a tumor, which can become malignant if they invade and spread to surrounding tissues. Like any other cancers, breast cancer has many risk factors that can't be changed, like family history.
› Verified 6 days ago
Lillian M. Teigland, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6324 Fairview Rd, Suite 201, Charlotte, NC 28210 Phone: 704-384-0588 Fax: 704-384-0580 | |
Felice A James, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 251 Eastway Dr, Charlotte, NC 28213 Phone: 704-446-9991 | |
Heather M. Burney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1801 Rozzelles Ferry Rd, Charlotte, NC 28208 Phone: 704-446-9987 | |
Dr. Jerome Howard, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6111 Rumple Rd, Charlotte, NC 28262 Phone: 704-596-5067 Fax: 704-599-9458 | |
Vishalakshi Kalyana Sundaram, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 Vail Ave, Ste 400, Charlotte, NC 28207 Phone: 704-304-7000 | |
Thamrah Rhoxana Wright, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1918 Randolph Rd Ste 275, Charlotte, NC 28207 Phone: 704-384-1354 | |
Dr. Carlos B Jorge, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 309 S Sharon Amity Rd Ste 206, Charlotte, NC 28211 Phone: 704-360-5018 Fax: 980-273-1102 |